Intrinsic value of Arcutis Biotherapeutics, Inc. (ARQT)
Live fair value data for Arcutis Biotherapeutics, Inc. (ARQT) is currently unavailable. Please check again shortly.
Current Price: $172.00
Valuation: Overvalued
Confidence: 5.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Arcutis Biotherapeutics, Inc. (ARQT) undervalued or overvalued?
Based on the current model output, Arcutis Biotherapeutics, Inc. appears to be overvalued with a downside of 10.00%.
Fair value vs market price — Arcutis Biotherapeutics, Inc. (ARQT)
Unlock premium access to view the live fair value comparison against current market price for ARQT.
Frequently Asked Questions - ARQT
How is ARQT intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for ARQT.
Is ARQT undervalued or overvalued right now?
ARQT is currently shown as overvalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for ARQT: open their intrinsic value pages.